LDN 2019 Conference - Friday Morning Q&A (LDN, low dose naltrexone)


LDN 2019 Conference - Friday Morning Q&A (2019 Conference) (LDN, low dose naltrexone)

Presentations on the below and questions were asked in relation to:

  1. Mechanism of Action Stephen Dickson, BSC (hons) MRPharmS
  2. The Role of LDN in Cancer Management Prof Angus Dalgleish, MD
  3. LDN to Quell the Over-reactive Autoimmune Conditions Kicked up by Many of the Drugs in the Cancer World Today Nasha Winters, ND
  4. Infections in Cancer and Autoimmune Disorders Armin Schwarzbach, PhD, MD
  5. Autoimmune Hepatitis Paul Battle, PA-C